Karen Malene Wegener

688 total citations
10 papers, 560 citations indexed

About

Karen Malene Wegener is a scholar working on Molecular Biology, Neurology and Biomaterials. According to data from OpenAlex, Karen Malene Wegener has authored 10 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Neurology and 3 papers in Biomaterials. Recurrent topics in Karen Malene Wegener's work include Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers) and Alzheimer's disease research and treatments (2 papers). Karen Malene Wegener is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers) and Alzheimer's disease research and treatments (2 papers). Karen Malene Wegener collaborates with scholars based in Denmark and United States. Karen Malene Wegener's co-authors include Kristina Bram Knudsen, A. Permin, Jens Lykkesfeldt, Thomas L. Andresen, Helle Northeved, Torben Gjetting, Steen Larsen, Pramod Kumar Ek, Kim Jantzen and Peter Möller and has published in prestigious journals such as Journal of Neuroscience, Toxicology and Nanomedicine Nanotechnology Biology and Medicine.

In The Last Decade

Karen Malene Wegener

9 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen Malene Wegener Denmark	7	244	142	107	95	64	10	560
Alice Polchi Italy	12	495 2.0×	200 1.4×	168 1.6×	143 1.5×	22 0.3×	20	921
Edison Salas‐Huenuleo Chile	12	419 1.7×	187 1.3×	89 0.8×	164 1.7×	20 0.3×	17	808
Bhairavi Srinageshwar United States	9	226 0.9×	104 0.7×	40 0.4×	72 0.8×	20 0.3×	20	433
Subhadeep Das India	15	425 1.7×	346 2.4×	323 3.0×	103 1.1×	177 2.8×	27	993
Dong‐qun Liu China	13	128 0.5×	79 0.6×	116 1.1×	138 1.5×	13 0.2×	15	433
Sascha Wien Germany	9	165 0.7×	156 1.1×	53 0.5×	75 0.8×	12 0.2×	13	445
Bindukumar Nair United States	18	386 1.6×	158 1.1×	35 0.3×	100 1.1×	11 0.2×	37	976
Yu Xiao China	20	460 1.9×	106 0.7×	106 1.0×	123 1.3×	16 0.3×	37	915
Ruichen Zhao China	13	491 2.0×	137 1.0×	48 0.4×	127 1.3×	22 0.3×	27	818

Countries citing papers authored by Karen Malene Wegener

Since Specialization

Citations

This map shows the geographic impact of Karen Malene Wegener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Malene Wegener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Malene Wegener more than expected).

Fields of papers citing papers by Karen Malene Wegener

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Malene Wegener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Malene Wegener. The network helps show where Karen Malene Wegener may publish in the future.

Co-authorship network of co-authors of Karen Malene Wegener

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Malene Wegener. A scholar is included among the top collaborators of Karen Malene Wegener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Malene Wegener. Karen Malene Wegener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Quaade, Michelle Lauge, et al.. (2025). Characterization of brain lesions in Danish farm mink (Neogale vison) with acute, fatal SARS-CoV-2 infection. Journal of Comparative Pathology. 219. 36–40.

Fjord‐Larsen, Lone, et al.. (2021). Nonclinical safety evaluation, pharmacokinetics, and target engagement of Lu AF82422, a monoclonal IgG1 antibody against alpha-synuclein in development for treatment of synucleinopathies. mAbs. 13(1). 1994690–1994690. 22 indexed citations

Alstrup, Aage Kristian Olsen, et al.. (2019). Effects of Long-term Anesthesia, Blood Sampling, Transportation, and Infection Status on Hearts and Brains in Pigs Inoculated with Staphylococcus aureus and Used for Imaging Studies. Journal of the American Association for Laboratory Animal Science. 59(1). 74–84. 3 indexed citations

Wegener, Karen Malene, Steen Larsen, Lassina Badolo, et al.. (2018). PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in rats. Toxicology. 395. 15–22. 42 indexed citations

Wegener, Karen Malene, et al.. (2015). Pigment Deposition in the Rat Retina. Toxicologic Pathology. 43(6). 890–892. 3 indexed citations

Knudsen, Kristina Bram, Helle Northeved, Pramod Kumar Ek, et al.. (2014). In vivo toxicity of cationic micelles and liposomes. Nanomedicine Nanotechnology Biology and Medicine. 11(2). 467–477. 287 indexed citations

Richmond, Emily, et al.. (2014). Vigabatrin-induced CNS changes in juvenile rats: Induction, progression and recovery of myelin-related changes. NeuroToxicology. 46. 137–144. 6 indexed citations

Knudsen, Kristina Bram, Helle Northeved, Torben Gjetting, et al.. (2014). Biodistribution of rhodamine B fluorescence-labeled cationic nanoparticles in rats. Journal of Nanoparticle Research. 16(2). 67 indexed citations

Knudsen, Kristina Bram, Helle Northeved, Pramod Kumar Ek, et al.. (2013). Differential toxicological response to positively and negatively charged nanoparticles in the rat brain. Nanotoxicology. 8(7). 1–33. 37 indexed citations

10.

Davtyan, Hayk, Anahit Ghochikyan, Irina Petrushina, et al.. (2013). Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial. Journal of Neuroscience. 33(11). 4923–4934. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact